F2RL1 and asthma: Since the function of CD14++CD16+ monocytes in asthma or other chronic inflammatory conditions is not known, the clinical significance of our observation of increased PAR-2 expression on CD14++CD16+ monocytes of patients with severe asthma is unclear.